Cigna Group (CI)
(Real Time Quote from BATS)
$351.80 USD
+3.02 (0.87%)
Updated Apr 19, 2024 10:58 AM ET
3-Hold of 5 3
A Value C Growth B Momentum B VGM
Income Statements
Fiscal Year end for Cigna Group falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 195,265 | 180,516 | 174,078 | 160,401 | 153,566 |
Cost Of Goods | 36,287 | 32,206 | 33,562 | 32,710 | 30,819 |
Gross Profit | 158,978 | 148,310 | 140,516 | 127,691 | 122,747 |
Selling & Adminstrative & Depr. & Amort Expenses | 150,442 | 139,896 | 132,581 | 119,538 | 114,670 |
Income After Depreciation & Amortization | 8,536 | 8,414 | 7,935 | 8,153 | 8,077 |
Non-Operating Income | -1,577 | 1,167 | 55 | 4,153 | 175 |
Interest Expense | 1,446 | 1,228 | 1,208 | 1,438 | 1,682 |
Pretax Income | 5,513 | 8,353 | 6,782 | 10,868 | 6,570 |
Income Taxes | 141 | 1,607 | 1,367 | 2,379 | 1,450 |
Minority Interest | 208 | 78 | 50 | 31 | 16 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5,372 | 6,746 | 5,415 | 8,489 | 5,120 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5,164 | 6,668 | 5,365 | 8,458 | 5,104 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11,571 | 11,351 | 10,858 | 10,955 | 11,728 |
Depreciation & Amortization (Cash Flow) | 3,035 | 2,937 | 2,923 | 2,802 | 3,651 |
Income After Depreciation & Amortization | 8,536 | 8,414 | 7,935 | 8,153 | 8,077 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 296.95 | 313.07 | 340.97 | 368.38 | 379.76 |
Diluted EPS Before Non-Recurring Items | 25.09 | 23.27 | 20.47 | 18.45 | 17.05 |
Diluted Net EPS (GAAP) | 17.39 | 21.30 | 15.73 | 22.96 | 13.44 |
Fiscal Year end for Cigna Group falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 51,114.00 | 49,048.00 | 48,586.00 | 46,517.00 |
Cost Of Goods | NA | 9,280.00 | 8,927.00 | 9,034.00 | 9,046.00 |
Gross Profit | NA | 41,834.00 | 40,121.00 | 39,552.00 | 37,471.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 39,774.00 | 37,881.00 | 37,331.00 | 35,456.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2,060.00 | 2,240.00 | 2,221.00 | 2,015.00 |
Non-Operating Income | NA | -1,512.00 | -35.00 | 26.00 | -56.00 |
Interest Expense | NA | 360.00 | 365.00 | 363.00 | 358.00 |
Pretax Income | NA | 188.00 | 1,840.00 | 1,884.00 | 1,601.00 |
Income Taxes | NA | -919.00 | 391.00 | 374.00 | 295.00 |
Minority Interest | NA | 78.00 | 41.00 | 50.00 | 39.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1,107.00 | 1,449.00 | 1,510.00 | 1,306.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1,029.00 | 1,408.00 | 1,460.00 | 1,267.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 294.84 | 297.05 | 296.75 | 298.82 |
Diluted EPS Before Non-Recurring Items | NA | 6.79 | 6.77 | 6.13 | 5.41 |
Diluted Net EPS (GAAP) | NA | 3.49 | 4.74 | 4.92 | 4.24 |